Prion Diseases
Prion diseases are a family of rare progressive neurodegenerative disorders that affect both humans and animals (Adapted from CDC, 2024, and WHO, no date).
Primary reference(s)
CDC, 2024. Prion Diseases. Centres for Disease Control and Prevention (CDC). Accessed 27 May 2025.
WHO, no date. Transmissible Spongiform Encephalopathies. Accessed 27 May 2025.
Annotations
Additional scientific description
These diseases affect the nervous system of mammals and, although the exact mechanism for transmission is as yet unknown, it is thought to be due to a putative infectious protein or protein-like substance called a prion, a ubiquitously expressed protein termed PrP or PrPc which undergoes conversion to an abnormal prion protein termed PrPsc (WHO, no date).
These diseases occur when proteins normally in the body misfold and cause illness. The misfolding leads to brain damage and other symptoms. Symptoms may take years to develop. But once they do, the disease rapidly progresses and leads to death. One of the reasons people may get sick with prion diseases is through eating or handling meat contaminated with prions. People may also become infected if they get prions in their bodies. This may occur through organ transplant or being exposed to contaminated equipment during surgery (CDC, 2024).
The term Transmissible Spongiform Encephalopathies (TSE) includes:
- Creutzfeldt-Jakob disease (CJD) in humans
- scrapie in sheep and goats
- chronic wasting disease in deer
- bovine spongiform encephalopathies (BSE) in cattle (WHO, no date)
Human
Many different prion diseases affect people, but some are more common than others. The most common prion disease in people is Creutzfeldt-Jakob disease (CJD). CJD is a prion disease that causes a person's brain to break down or stop working normally. Once symptoms start, the disease progresses quickly. It is always fatal, usually within a year. CJD is sometimes called "classic CJD" to avoid confusion with variant CJD. Most cases of classic CJD are in older people. They appear sporadically. This means there is no known reason that the cases begin.
A smaller number of cases occur in people who inherited genetic changes that make them prone to CJD. Occasionally, there have also been illnesses in people who were exposed to surgical equipment or other products contaminated with prions (CDC, 2024).
Another prion disease, variant Creutzfeldt-Jakob disease (vCJD), has a similar name but is a different, much rarer, disease (CDC, 2024). vCJD is a rare and fatal human neurodegenerative condition first described in March 1996. As with CJD, vCJD is classified as a TSE because of characteristic spongy degeneration of the brain and its ability to be transmitted. The development of vCJD is strongly linked with exposure, probably through the consumption of meat and meat products, to the agent causing BSE which was first reported in the UK in 1986. In contrast to the traditional forms of CJD (sporadic, familial, and iatrogenic), vCJD has affected younger patients, average age of 29 years, compared to >65 years for the other forms. vCJD has a relatively longer duration of illness, median of 14 months, compared to 4.5 months for CJD (WHO, no date).
Creutzfeldt-Jakob disease (vCJD) is tied to eating beef from a cow that had a prion disease called Bovine Spongiform Encephalopathy (BSE). It was discovered in 1996 in the United Kingdom. The disease affected much younger people than CJD. vCJD often infected people in their 20s or younger. It caused mental symptoms and behaviours, as well as pain when touching things (dysesthesias), that CJD does not (CDC, 2024).
Other prion diseases include kuru, variably protease-sensitive prionopathy, sporadic fatal insomnia, and inherited forms caused by genetic mutations (CDC, 2024). It is a non-inflammatory neurodegenerative disease and is a form of transmissible spongiform encephalopathy transmitted through the act of cannibalism (Asher, 2018). The symptoms of kuru progress rapidly with cerebellar and extrapyramidal signs and symptoms, with death occurring within one to two years of the onset of symptoms (Gajdusek, 1957).
The World Health Organization (WHO) has published guidance on case classification and surveillance standards for vCJD and other human-transmissible prion diseases (WHO, 2003).
Animal
There are a number of known prion diseases in animals:
Bovine spongiform encephalopathy (BSE):
BSE is a type of prion disease that affects cows. The first cases were identified in the mid-1980s, but BSE didn't gain widespread attention until a major outbreak in the United Kingdom later that decade into the 1990s. Millions of cows were infected.
By 2005, 24 countries had reported BSE among native cattle. (20 of the 24 were in Europe).
The spread of infection in cattle was likely tied to feeding practices. It is speculated that it is related to cows being fed meat and bone meal from other cows that had prion disease (CDC, 2024).
Chronic Wasting Disease (CWD):
CWD is a prion disease that affects animals like deer, elk, moose, and reindeer. It has been found in the United States, Canada, Norway, Finland, and Sweden. Imported cases have also been reported in South Korea. Though there have been no cases of CWD in people, experts think it poses a theoretical risk to people. This is because CWD is related to BSE, which has caused disease in people. If CWD could spread to people, hunters and people who eat meat from CWD-infected animals would likely be most at risk (CDC, 2024).
Scrapie:
The term scrapie encompasses two different pathological entities: classical and atypical scrapie. Both conditions are chronic, neurodegenerative, fatal diseases of sheep and goats and are caused by similar agents. However, they differ in clinical presentation, pathogenesis, pathology, biochemical properties and epidemiology. Classical scrapie is characterised by vacuolar changes in the central nervous system (CNS). It has been recognised as a clinical disorder for more than 250 years and is classified as a transmissible spongiform encephalopathy (TSE), or prion disease, as defined by the accumulation of an abnormal form of a host cell membrane-bound glycoprotein (prion protein or PrP) referred to as PrPSc, in the CNS. Polymorphisms of the PrP gene are associated with susceptibility to scrapie. The more recently identified condition known as atypical scrapie has some clinical and pathological features similar to classical scrapie but is not considered to be transmitted in field situations. The epidemiology is consistent with a non-contagious condition that occurs sporadically. Classical scrapie may be transmitted from dam to offspring in the period from parturition to weaning, and in utero. It can also be transmitted horizontally to unrelated sheep or goats. The infectious material can persist for several years in pastures and in buildings. Foetal membranes are a source of infection, and milk from clinically affected animals can transmit disease. The incubation time between primary infection and clinical disease is usually longer than 1 year and may sometimes exceed the commercial lifespan of the animal. The majority of cases occur between 2 and 5 years of age. Clinical disease develops only if the agent enters the CNS. Atypical scrapie, where it presents clinically, is reported mostly in older animals, and occurs with a geographical distribution suggestive of a spontaneous disease, although it has been transmitted experimentally. There are no vaccines available. There is no evidence of a causal link between classical or atypical scrapie and human TSEs (WOAH, no date).
Metrics and numeric limits
Not applicable.
Key relevant UN convention / multilateral treaty
International Health Regulations (2005), 3rd ed. (WHO, 2016).
Drivers
Acquired human prion diseases are rare. In these instances, the most common outside sources are either medical procedures, where an individual may be exposed to the abnormal prion protein via contaminated equipment or certain transplanted human tissues, or via ingestion of meat from cattle infected with BSE (linked to vCJD). Other prion diseases such as scrapie and chronic wasting disease can be transmitted between animals, however transmission from animals to humans has only been observed in BSE/vCJD (WHO, 2003).
There is also concern about the possibility that bovine-derived materials involved in the production of vaccines and other pharmaceutical products could represent a way of potential transmission of the disease. Foetal calf serum is a widespread component of growth media, and other media components such as enzymes, and hormones are extracted from cattle. Additionally, bovine materials have been used in a variety of materials such as gelatine, a component of capsules. An intense regulatory effort has therefore been made to eliminate materials potentially contaminated with BSE from all stages of production. Where bovine materials are still required, they must be sourced from geographical areas that are not endemic for BSE. In addition, difficult regulatory decisions have been necessary where the relative risks inherent in replacing fully characterized materials (such as vaccine seed strains) are compared with the mathematically small risk of vCJD transmission. The field is also complicated by the difficulty in assaying materials for TSEs, and in conducting studies to detect major routes of transmission and infection of this highly novel class of pathogen (WHO, no date).
In 2006 a WHO report stated that the eventual impact of human exposures to BSE agent and secondary transmissions of vCJD via blood, blood components and plasma-derived products cannot be predicted (WHO. 2006). It also reported that blood programs and national authorities should consider carefully, in advance, the potential impact of screening donors for TSE-including the implications of notification for persons testing positive, their families and society, as well as on the blood supply (WHO, 2006).
Impacts
Bovine spongiform encephalopathy (BSE) is a progressive, fatal disease of the nervous system of bovines that is caused by the accumulation of an abnormal protein called ‘prion’ in nervous tissue. Two forms can be distinguished: classical BSE (caused by C-type BSE agent), which occurs in bovines after ingesting prion-contaminated feed, and atypical BSE (caused by H- and L-type agents), which is believed to occur spontaneously in all bovine populations. Classical BSE was first detected in 1986, and the implementation of appropriate control measures resulted in its decline worldwide. To date, the incidence of both forms is negligible and estimated to approach zero cases per million bovines. Classical BSE is considered zoonotic due to its assumed link with the emergence of variant Creutzfeldt-Jakob disease in humans. Classical BSE is a WOAH-listed disease, for which WOAH has established official recognition of sanitary risk status (WOAH, 2023).
Multi-hazard context
Concern about iatrogenic (i.e. illness caused by medical examination or treatment) spread of prion-related disease from the use of contaminated corneal and dura mater grafts, neurosurgical equipment, and cadaver-derived human growth hormone and bloodborne transmission of vCJD has long been suspected as possible because of some unusual features of the disease (Belay & Schonberger, 2005).
Risk Management
In order to update the preventive measures proposed by the World Health Organization (WHO) in 1997 to minimize the risks associated with the use of vaccines, blood products and other pharmaceutical products containing bovine-derived and human-derived materials, a meeting of international experts was convened at WHO in Geneva on 3-5 February 2003. The purpose was to review the latest available data on the epidemiology, antemortem and post-mortem diagnosis, detection of the infectious agents, and distribution of infectivity in tissues or body fluids of relevant species with TSEs (WHO, 2003).
Monitoring
WHO supports countries to conduct all-hazards strategic risk assessment in the contexts of health emergencies and disasters, which results in the development of a country risk profile. Empowered with the country risk profile, inclusive of a seasonal risk calendar, countries can anticipate potential emergencies before they occur to trigger early alerts and inform early actions (WHO, 2021).
WHO's Early Warning, Alert and Response System (EWARS) has been designed to improve disease outbreak detection in emergency settings, such as in countries in conflict or following a natural disaster. It is a simple and cost-effective way to rapidly set up a disease surveillance system. EWARS is deployed during an emergency as an adjunct to the national disease surveillance system. WHO works with Ministries of Health and health sector partners to train local health workers to use the system. After the emergency, EWARS should re-integrate back into the national system (WHO, no date).
References
Asher, D.M., Gregori, L., 2018. Human transmissible spongiform encephalopathies: historic view. Handb Clin Neurol. 153:1-17. doi: 10.1016/B978-0-444-63945-5.00001-5. PMID: 29887130. Accessed 24 May 2025.
Belay, E.D., Schonberger, L.B., 2005. The public health impact of prion diseases. Annu Rev Public Health. 26:191-212. doi: 10.1146/annurev.publhealth.26.021304.144536. PMID: 15760286. Accessed 24 May 2025.
Gajdusek, D.C., Zigas, V., 1957. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N Engl J Med. 257(20):974-8. doi: 10.1056/NEJM195711142572005. PMID: 13483871. Accessed 25 May 2025.
CDC, 2024. Prion Diseases. Centres for Disease Control and Prevention (CDC). https://www.cdc.gov/prions/about/index.html www.cdc.gov/prions Accessed 14 September 2020.15 February 2025 WHO, no date. Transmissible Spongiform Encephalopathies. Accessed 15 February 2025.
WHO, 2003. Manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt- Jakob disease. World Health Organization (WHO). Accessed 15 February 2025.
WHO, 2006. WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies. World Health Organization (WHO). Accessed 18 April 2025.
WHO, 2016. International Health Regulations (2005), 3rd ed. World Health Organization (WHO). Accessed 26 May 2025.
WHO, 2021. Strategic toolkit for assessing risks (STAR): a comprehensive toolkit for all-hazards health emergency risk assessment. World Health Organization (WHO). Accessed 13 February 2025.
WHO, no date. Early Warning, Alert and Response System (EWARS). World Health Organization (WHO). Accessed 18 April 2025.
WOAH, 2023. Bovine spongiform encephalopathy. World Organisation for Animal Health (WOAH). Accessed 15 February 2025.
WOAH, no date. Scrapie, World Organization for Animal Health (WOAH). Accessed 27 May 2025.